Furthermore, indole-3-aldehyde mediates anti-tumor immunity by activating AhR in CD8+ T cells to promote IFN-γ production, and by promoting the ligand-dependent differentiation of CD4+ T cells into Th17 or Treg cells, ultimately enhancing the efficacy of immune checkpoint inhibitors (146). The gene discussed is CD4; the disease is neoplasm.